coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Sasse Network 2 PCN, Spelthorne · Health Inequalities Profile

    PCN U58525 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    39,674

    Registered population

    62.2% aged 18–64

    17.8%

    Aged 65+

    ICB 18.8% · England 17.9%

    20.8%

    Ethnic minority (non-White)

    12.6% Asian · England 9.6%

    0.7%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    ~290

    Core20 residents (est.)

    Resident basis; registered basis ~262 · see page 3

    5,802

    Hypertension register

    +7.33% in 3 yrs · England +5.60%

    328

    SMI register

    36.9% of Spelthorne's

    502

    COPD register

    Reviews +1.82% in 3 yrs

    Forecast to 2030

    7,425

    Hypertension patients, 2030

    +1,623 on today

    76.6%

    QRISK ≥20% on statins, 2030

    +5.36pp over 3 yrs

    4.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -8.5 pp
    Smoking cessation support offers fell over three years.

    Recorded smoking support offered fell 8.5 pp over 2023 to 2025 to 88.4% (Spelthorne 95.1%, ICB 94.3%, England 94.2%, +0.1 pp).

    37.3 pp
    Wide practice variation in vaccination and phone access.

    QOF vaccination achievement spans 37.3 pp from Virginia Water Medical Practice (34.6%) to Grove Medical Centre (71.9%), alongside a 38.4 pp phone-access range.

    85.0%
    Annual review achievement exceeds national and local benchmarks.

    Annual reviews exceed England for heart failure at 85.0% (England 78.5%), COPD at 89.8% (England 76.4%), and asthma at 84.0% (England 65.7%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Projected population growth of 8.8% outpaces England while Asian residents reach 12.6%

    SASSE NETWORK 2 PCN registers 39,674 patients. Those aged 65+ comprise 17.8% (7,074 patients; Spelthorne 17.4%, NHS Surrey Heartlands Integrated Care Board 18.8%, England 17.9%). Children aged 0-17 represent 20.0% (7,933 patients; Spelthorne 20.3%, ICB 20.4%, England 19.6%). Projected list growth to 2030 is 8.8% (methodology unverified). Census data for associated areas shows Asian residents comprise 12.6% (Spelthorne 12.8%, ICB 7.7%, England 9.6%) and White residents 79.2% (Spelthorne 78.7%, ICB 85.3%, England 81.1%).

    Age profile

    0–1720.0%
    18–6462.2%
    65+17.8%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White79.2%
    Asian12.6%
    Mixed3.7%
    Other2.3%
    Black2.2%

    Older people · falls rows are Spelthorne local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Spelthorne LA)1,8752,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.8%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.6%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Spelthorne LA)9509819552024/25
    Falls deaths, all ages, per 100,000 (Spelthorne LA)10.714.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 0.7% overall and concentrated entirely within Grove Medical Centre

    SASSE NETWORK 2 PCN's Core20 share is 0.7% (Spelthorne 1.8%, NHS Surrey Heartlands Integrated Care Board 0.8%, England 21.0%), with an average IMD decile of 7.4 (England 5.5). Registered Core20 patients concentrate at Grove Medical Centre (1.8% share, 262 estimated patients), whereas the other four practices record 0.0%. Resident models estimate about 290 people in deciles 1 and 2 (52 aged 0-17), though resident estimates do not reconcile directly with registered lists. Core20 outreach should focus on Grove Medical Centre rather than dispersing resources network-wide.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Grove1.8% · 262 patients
    Knowle Green0.0% · 0 patients
    Fordbridge0.0% · 0 patients
    Virginia Water0.0% · 0 patients
    Orchard0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    328

    SMI register

    0.80% recorded prevalence

    167

    Learning disability register

    0.41% recorded prevalence

    12

    Care homes, 614 beds

    In the PCN catchment

    8.6%

    Provide unpaid care

    Spelthorne, Census 2021

    The PCN records 167 patients on the learning disability register (0.4%; Spelthorne 0.4%, NHS Surrey Heartlands Integrated Care Board 0.5%, England 0.6%) and 328 on the severe mental illness register (0.8%; Spelthorne 0.8%, ICB 0.8%, England 1.0%). The catchment contains 12 care homes with 614 beds. Crude register prevalence does not establish unmet need or under-detection, which would require clinical record audits to assess, alongside care home coordination.

    Severe mental illness: physical health checks

    Severe mental illness prevalence is 0.8% (England 1.0%). Published checks show 83.5% blood pressure (England 83.4%) and 82.7% BMI (England 82.1%); unmeasured elements cannot imply completion. Smoking support offered fell 8.5 pp (England +0.1 pp) to 88.4% (England 94.2%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,802

    Hypertension register

    +7.33%

    Register growth, 3 yrs

    Spelthorne +4.33% · England +5.60%

    +3.71pp

    BP control, under 80

    ≤140/90 · +3.22pp aged 80+

    +1,623

    More patients by 2030

    Forecast 7,425 (16.36%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 14.2% (5,802 patients), below Spelthorne (15.7%) and England (15.2%), though practice rates range from 13.0% at Knowle Green Medical to 16.3% at Virginia Water Medical Practice. Over 2023 to 2025, prevalence rose 1.0 pp (England +0.8 pp). While 91.1% of patients have a recent blood pressure reading (England 90.0%), blood pressure control under age 80 is 66.2%, trailing England (67.8%) and NHS Surrey Heartlands Integrated Care Board (68.1%), whereas control at age 80+ reaches 80.9% (England 81.2%). Observation periods for registers were not supplied. Blood pressure control in patients under 80 trails national benchmarks despite high testing coverage, indicating an opportunity to prioritise clinical treatment intensification.

    Lipids and statins

    Statin therapy reaches 64.3% in patients with QRISK ≥ 20% (England 63.6%) and 86.7% for diabetes with cardiovascular disease (England 84.4%), though CKD uptake is 69.8% (England 70.3%). With lipid therapy exceeding England benchmarks across primary and secondary prevention, the PCN can prioritise closing the small treatment gap in chronic kidney disease.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202654,159£2.10£2.24£1.86£113,734
    Cardiovascular (all), 202569,802£4.36£4.74£3.33£304,337

    In 2026, the PCN prescribed 54,159 lipid-modifying items at £2.10 per item (spend £113,734). The PCN spent £7,582 less than at NHS Surrey Heartlands Integrated Care Board's unit cost (£2.24), but £12,998 more than at England's unit cost (£1.86). Higher unit costs relative to England suggest an opportunity to examine lipid-modifying formulary choices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +6.45%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +4.20%

    Asthma prevalence, PCN 3-yr % change

    COPD recorded prevalence is 1.2% (502 patients), below England (1.9%), Spelthorne (1.5%), and NHS Surrey Heartlands Integrated Care Board (1.3%), with three-year prevalence falling 0.5% (England +2.6%). However, COPD annual reviews reach 89.8%, above England (76.4%) and Spelthorne (85.9%). Similarly, asthma prevalence is 5.2% (1,993 patients), below England (6.6%), but reviews reach 84.0% (England 65.7%), leaving an estimated 319 patients without a recorded review. High review achievement alongside lower prevalence is consistent with strong care processes for registered patients.

    Cancer register and children's immunisation

    Cancer prevalence is 4.0% (1,618 patients), above England (3.8%) but below NHS Surrey Heartlands ICB (4.5%). For childhood immunisations, 6-in-1 coverage at 12 months reaches 96.2% (exceeding the 95.0% target). However, age-five cohorts trail: MMR dose 1 is 92.3% and dose 2 is 88.5% (a 3.8 pp difference, below target by 6.5 pp), while 4-in-1 booster coverage is 85.4% (below target by 9.6 pp).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.2%

    England 91.0%

    6-in-1 complete primary course at 24 months96.1%

    England 92.2%

    MMR dose 1 at 24 months92.2%

    England 88.3%

    MMR dose 2 at age 588.5%

    England 82.8%

    4-in-1 pre-school booster at age 585.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    In 2022, 61.4% of cancers with a known stage in NHS Surrey Heartlands ICB (2,955 of 4,810) were diagnosed at stage 1 or 2, above England (55.3%) but 13.6 percentage points below the 75.0% national ambition by 2028, representing about 650 extra early-stage cases a year. Staging coverage was 67.7% (4,810 of 7,106 registered cancers). Early-stage shares ranged from 88.2% in breast (704 of 798) and 76.7% in cervix (23 of 30) to 48.1% in bowel (301 of 626) and 33.2% in lung (165 of 497); site-specific small numbers warrant caution. PCN cervical screening coverage is 69.4% (England 66.8%), though Knowle Green Medical records 65.9%.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), Ashford and St Peter's Hospitals NHS Foundation Trust achieved 76.4% on the cancer 62-day referral to treatment standard, 8.6 percentage points below the 85.0% standard, trailing The Hillingdon Hospitals NHS Foundation Trust (84.0%) and Frimley Health NHS Foundation Trust (81.8%), but above NHS Surrey and Sussex Integrated Care Board (71.5%) and England (71.2%). The trust met the 28-day faster diagnosis standard at 85.5% (standard 75.0%). Diagnostic 6+ week waits at the trust were 49.6% for colonoscopy (England 30.8%) and 28.4% for non-obstetric ultrasound (England 19.6%).

    Pathways within standard (%)Ashford and St Peter'sHillingdonFrimley HealthSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)85.5379.6387.9579.2979.32
    31-day treatment (96%)94.2196.6792.8990.4592.50
    62-day referral to treatment (85%)76.3884.0581.8471.5171.16
    Diagnostic waits over 6 weeks (%)Ashford and St Peter'sHillingdonFrimley HealthEngland
    MRI0.093.9912.8521.40
    CT9.273.210.639.92
    Echocardiography0.970.923.3528.48
    Colonoscopy49.6126.5822.8430.83
    Gastroscopy56.7426.567.4329.02
    All 15 DM01 tests23.1210.987.4923.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In June 2026 (provisional), Community Services Dataset activity shows that 69.6% of contacts with borough residents (76,215 of 109,530 contacts) were with adults aged 65 and over. These data reflect activity across Spelthorne residents rather than PCN-specific cohorts, highlighting that older adults account for the large majority of local community-service provision.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 38.4 pp and vaccination achievement spans 37.3 pp across practices

    Overall 2025/26 QOF achievement ranges from 81.7% at Knowle Green Medical to 95.1% at Fordbridge Medical Centre against 92.5% in England. Clinical achievement reaches 100.0% at Fordbridge Medical Centre, but vaccination and immunisation achievement varies across practices by 37.3 pp, from 34.6% at Virginia Water Medical Practice to 71.9% at Grove Medical Centre (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Orchard1230.074.3%79.1%91.4%
    Knowle Green920.064.1%78.2%79.7%
    Virginia Water1080.061.1%78.0%79.6%
    Grove1091.841.8%68.7%76.6%
    Fordbridge1180.035.9%80.1%72.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSpelthorneAssetPCNSpelthorne
    Care homes (catchment)12 (614 beds)n/aSchools (catchment)57n/a
    Children's centres56Places of worship5143
    Libraries41Homelessness support (VCS)0no data
    Day centres (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)118Primary academies68

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Heart failure register case-finding review

    Recorded heart failure prevalence is 0.8% (313 of 39,674 patients) against Spelthorne 1.0% and England 1.1%, a benchmark scenario range of +90 to +123 patients. For discussion, practices could search clinical records for uncoded heart failure diagnoses, prioritising Grove Medical Centre by list size and Core20 volume. Low cost, quick to run.

    Option 2

    Smoking cessation support offer recovery

    Smoking cessation support offered is 88.4% (Spelthorne 95.1%, ICB 94.3%, England 94.2%) after falling 8.5 pp over 2023 to 2025 (England +0.1 pp). For discussion, the PCN could standardise clinical review templates and opportunistic smoking support prompts during long-term condition reviews, starting at Grove Medical Centre. Low cost, quick to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Vaccination and asthma recall alignment

    QOF vaccination achievement spans 37.3 pp from Virginia Water Medical Practice (34.6%) to Grove Medical Centre (71.9%; England 55.2%), while 84.0% asthma reviews leave 319 of 1,993 patients unreviewed. For discussion, practices could align call-recall workflows between Grove Medical Centre and Virginia Water Medical Practice and run asthma recalls. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Culturally tailored primary care outreach (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Smoking cessation support recall (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension blood pressure control review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening uptake review (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026Practice
    Practice telephony and access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Heart failure register case-finding review (p12)Heart failure register · Heart Failure: QOF prevalence · Registered population—PCN
    Option 2 · Smoking cessation support offer recovery (p12)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Option 3 · Vaccination and asthma recall alignment (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15